Billion Ship Pharmaceuticals Large Molecule Gene Recombination Project Base Passed the European Union EU-QP Audit.

On March 10th, according to Yifan Pharmaceuticals, recently, Yifan Pharmaceuticals' large molecule gene recombinant project base - Hefei Xinzhu Biotechnology Co., Ltd. successfully passed the audit by the European Union quality authorization person and obtained the European QP compliance statement. Yifan Pharmaceuticals stated that this marks a key step for the company in advancing the international clinical layout of biosimilar drugs, laying a solid compliance foundation for the products to enter the European Union for clinical trials.